Clinical Practice Update on Infectious Endocarditis.


Journal

The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200

Informations de publication

Date de publication:
01 2020
Historique:
received: 27 07 2019
revised: 05 08 2019
accepted: 05 08 2019
pubmed: 16 9 2019
medline: 18 4 2020
entrez: 16 9 2019
Statut: ppublish

Résumé

Infectious endocarditis is a highly morbid disease with approximately 43,000 cases per year in the United States. The modified Duke Criteria have poor sensitivity; however, advances in diagnostic imaging provide new tools for clinicians to make what can be an elusive diagnosis. There are a number of risk stratification calculators that can help guide providers in medical and surgical management. Patients who inject drugs pose unique challenges for the health care system as their addiction, which is often untreated, can lead to recurrent infections after valve replacement. There is a need to increase access to medication-assisted treatment for opioid use disorders in this population. Recent studies suggest that oral and depo antibiotics may be viable alternatives to conventional intravenous therapy. Additionally, shorter courses of antibiotic therapy are potentially equally efficacious in patients who are surgically managed. Given the complexities involved with their care, patients with endocarditis are best managed by multidisciplinary teams.

Identifiants

pubmed: 31521667
pii: S0002-9343(19)30725-9
doi: 10.1016/j.amjmed.2019.08.022
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Delayed-Action Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-49

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sami El-Dalati (S)

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor. Electronic address: seldalat@med.umich.edu.

Daniel Cronin (D)

Division of Hospital Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor.

Michael Shea (M)

Department of Cardiovascular Medicine, University of Michigan, Ann Arbor.

Richard Weinberg (R)

Department of Cardiovascular Medicine, University of Michigan, Ann Arbor.

James Riddell (J)

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.

Laraine Washer (L)

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.

Emily Shuman (E)

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.

James Burke (J)

Department of Neurology, University of Michigan, Ann Arbor.

Sadhana Murali (S)

Department of Neurology, University of Michigan, Ann Arbor.

Christopher Fagan (C)

Department of Cardiovascular Medicine, University of Michigan, Ann Arbor.

Twisha Patel (T)

College of Pharmacy, University of Michigan, Ann Arbor.

Kirra Ressler (K)

Department of Cardiac Surgery, University of Michigan, Ann Arbor.

George Michael Deeb (GM)

Department of Cardiac Surgery, University of Michigan, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH